IRF6 PATHWAYS AND GENE TARGETS IN PALATE DEVELOPMENT

味觉发育中的 IRF6 通路和基因靶标

基本信息

  • 批准号:
    7479131
  • 负责人:
  • 金额:
    $ 38.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-01 至 2009-07-31
  • 项目状态:
    已结题

项目摘要

The goal of Project 0003 is to discover the genes that contribute to isolated cleft lip and palate, a common disorder with complex etiology. This project will study IRF6, a gene that encodes the transcription factor Interferon Regulatory Factor 6. Mutations in IRF6 cause Van der Woude syndrome (VWS). VWS is an outstanding clinical model for isolated cleft lip and palate because the phenotypes of VWS and isolated cleft lip and palate are similar. It is also an outstanding genetic model, since alleles of IRF6 are highly associated with isolated cleft lip and palate in nine geographically distinct populations. These results prove that IRF6 is a key component of a critical pathway in palate development. In this proposal we use mouse models to identify the IRF6 pathway and other genes therein. There are two main hypotheses, 1) IRF6 is a mediator of Tgfb signaling and 2) IRF6 gene targets are essential for palate development. There are three Specific Aims. Specific Aim 1 will determine which cell-type expresses Irf6 in the palate. This basic information will immediately suggest Irf6 pathways and gene targets. Specific Aim 2 will determine which pathways require Irf6 for palate development. The Tgfb3 signaling pathway is essential for palate development and Tgfb3 is expressed at about the same time and place as Irf6. Knockout mice will be used to test the hypotheses that Tgfb3 is essential for expression of Irf6 in the palate shelves. Specific Aim 3 will use microarray analysis to identify the target genes for Irf6 during palate development. In addition, if Irf6 is a mediator for Tgfb3, then gene expression in the palate will be similar in Tgfb3-/- and Irf6-/- mice. Addressing these aims will advance our understanding of Irf6, a gene that is essential in craniofacial development. Further, the IRF6 pathways and targets, discovered in this proposal, will be assessed for their involvement in cleft lip and palate in Project 0001 and in palate development in Project 0004 and Cores 9003 and 9004. This aggregate knowledge will enhance our ability to determine the causes of, and develop preventive interventions for, orofacial clefts.
项目0003的目标是发现导致孤立性唇腭裂的基因,唇腭裂是一种病因复杂的常见疾病。该项目将研究IRF 6,一种编码转录因子干扰素调节因子6的基因。IRF 6突变导致货车德沃德综合征(VWS)。VWS与单纯性唇腭裂的表型相似,是孤立性唇腭裂的一种优秀的临床模型。它也是一个杰出的遗传模型,因为IRF 6的等位基因与9个地理上不同的人群中的孤立性唇腭裂高度相关。这些结果证明IRF 6是腭发育中关键途径的关键组分。在这个建议中,我们使用小鼠模型来识别 IRF 6通路和其中的其他基因。有两个主要假设,1)IRF 6是Tgfb信号传导的介导者,2)IRF 6基因靶标对于腭发育是必需的。有三个具体目标。 具体目标1将确定哪种细胞类型在腭中表达Irf 6。这些基本信息将立即提示Irf 6途径和基因靶点。具体目标2将确定哪些途径需要Irf 6用于腭发育。Tgfb 3信号通路对于腭发育是必需的,并且Tgfb 3与Irf 6在大约相同的时间和位置表达。将使用敲除小鼠来检验Tgfb 3对于Irf 6在腭架中的表达是必需的这一假设。Specific Aim 3将使用微阵列分析来鉴定在腭发育期间Irf 6的靶基因。此外,如果Irf 6是Tgfb 3的介体,那么在Tgfb 3-/-和Irf 6-/-小鼠中腭中的基因表达将是相似的。实现这些目标将促进我们对Irf 6的理解,Irf 6是颅面发育中必不可少的基因。此外,IRF 6途径和目标,发现在这个建议,将评估他们参与唇腭裂, 项目0001和项目0004以及核心9003和9004中的腭开发。这些知识的积累将提高我们确定口面裂的原因和制定预防措施的能力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRIAN C SCHUTTE其他文献

BRIAN C SCHUTTE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRIAN C SCHUTTE', 18)}}的其他基金

IRF6 PATHWAYS AND GENE TARGETS IN PALATE DEVELOPMENT
味觉发育中的 IRF6 通路和基因靶标
  • 批准号:
    7666237
  • 财政年份:
    2008
  • 资助金额:
    $ 38.28万
  • 项目类别:
IRF6 PATHWAYS AND GENE TARGETS IN PALATE DEVELOPMENT
味觉发育中的 IRF6 通路和基因靶标
  • 批准号:
    6845929
  • 财政年份:
    2004
  • 资助金额:
    $ 38.28万
  • 项目类别:
CLONING AND CHARACTERIZATION OF THE VAN DER WOUDE GENE
VAN DER WOUDE 基因的克隆和表征
  • 批准号:
    6651305
  • 财政年份:
    2002
  • 资助金额:
    $ 38.28万
  • 项目类别:
CLONING AND CHARACTERIZATION OF THE VAN DER WOUDE GENE
VAN DER WOUDE 基因的克隆和表征
  • 批准号:
    6617324
  • 财政年份:
    2002
  • 资助金额:
    $ 38.28万
  • 项目类别:
CLONING AND CHARACTERIZATION OF THE VAN DER WOUDE GENE
VAN DER WOUDE 基因的克隆和表征
  • 批准号:
    6379968
  • 财政年份:
    2000
  • 资助金额:
    $ 38.28万
  • 项目类别:
CLONING AND CHARACTERIZATION OF THE VAN DER WOUDE GENE
VAN DER WOUDE 基因的克隆和表征
  • 批准号:
    6027902
  • 财政年份:
    2000
  • 资助金额:
    $ 38.28万
  • 项目类别:
Cloning and characterization of the Van Der Woude gene
Van Der Woude 基因的克隆和表征
  • 批准号:
    7467631
  • 财政年份:
    2000
  • 资助金额:
    $ 38.28万
  • 项目类别:
Cloning and characterization of the Van Der Woude gene
Van Der Woude 基因的克隆和表征
  • 批准号:
    7216257
  • 财政年份:
    2000
  • 资助金额:
    $ 38.28万
  • 项目类别:
Cloning and characterization of the Van Der Woude gene
Van Der Woude 基因的克隆和表征
  • 批准号:
    7413639
  • 财政年份:
    2000
  • 资助金额:
    $ 38.28万
  • 项目类别:
CLONING AND CHARACTERIZATION OF THE VAN DER WOUDE GENE
VAN DER WOUDE 基因的克隆和表征
  • 批准号:
    6523890
  • 财政年份:
    2000
  • 资助金额:
    $ 38.28万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 38.28万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 38.28万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 38.28万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 38.28万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 38.28万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 38.28万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 38.28万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 38.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 38.28万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 38.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了